RetinalGenix Technologies (RTGN) Accumulated Expenses (2021 - 2026)
RetinalGenix Technologies (RTGN) reported Accumulated Expenses of $20239.0 for Q1 2026, up 23.42% on a YoY basis from $16399.0 in Q1 2025, and up 4.98% sequentially from $19279.0 in Q4 2025.
RetinalGenix Technologies (RTGN) Accumulated Expenses (2021 - 2026) Analysis & Trends
RetinalGenix Technologies (RTGN) has 6 years of Accumulated Expenses data on file, last reported at $20239.0 in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses rose 23.42% year-over-year to $20239.0; the trailing twelve-month figure through Mar 2026 stood at $20239.0 (up 23.42% YoY), and the FY2025 full-year result was $19279.0, up 24.87% from the prior year.
- Accumulated Expenses advanced to $20239.0 in Q1 2026, from $19279.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $20239.0 in Q1 2026 to a low of $4079.0 in Q1 2022.
- A 5-year average of $12494.3 and a median of $12559.0 in 2024 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses soared 476.19% in 2022 and rose 23.42% in 2026, its largest moves.
- Tracing RTGN's Accumulated Expenses over 5 years: stood at $7759.0 in 2022, then jumped by 49.49% to $11599.0 in 2023, then surged by 33.11% to $15439.0 in 2024, then advanced by 24.87% to $19279.0 in 2025, then advanced by 4.98% to $20239.0 in 2026.
- Business Quant data shows RTGN's Accumulated Expenses at $20239.0 in Q1 2026, $19279.0 in Q4 2025, and $18319.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,239.00 |
| Dec 31, 2025 | 19,279.00 |
| Sep 30, 2025 | 18,319.00 |
| Jun 30, 2025 | 17,359.00 |
| Mar 31, 2025 | 16,399.00 |
| Dec 31, 2024 | 15,439.00 |
| Sep 30, 2024 | 14,479.00 |
| Jun 30, 2024 | 13,519.00 |
| Mar 31, 2024 | 12,559.00 |
| Dec 31, 2023 | 11,599.00 |
| Sep 30, 2023 | 10,639.00 |
| Jun 30, 2023 | 9,679.00 |
| Mar 31, 2023 | 8,719.00 |
| Dec 31, 2022 | 7,759.00 |
| Sep 30, 2022 | 6,799.00 |
| Jun 30, 2022 | 5,539.00 |
| Mar 31, 2022 | 4,079.00 |
| Dec 31, 2021 | 2,619.00 |
| Sep 30, 2021 | 1,180.00 |